[an error occurred while processing this directive]

Interpretation on the 2023 clinical practice guidelines of plasma component purification technology from the American Society for Apheresis (9th edition) 

  • WAN Li ,
  • WANG Mei
Expand
  • Blood Purification Center, Department of Nephrology, Peking University International Hospital, Beijing 102206, China; 2Department of Nephrology, Peking University People's Hospital, Beijing 100044, China

Received date: 2023-08-22

  Revised date: 2023-09-29

  Online published: 2024-01-12

Abstract

 In April 2023, the American Society for Apheresis (ASFA) released the 9th edition of guidelines for clinical practice of therapeutic apheresis. Based on published literature, these guidelines define the quality of evidence and the recommended strength of therapeutic apheresis in the treatment of diseases, and discuss the clinical application of therapeutic apheresis in 91 disease (166 indications). This article focuses on the interpretation of clinical multidisciplinary applications of plasma component purification technology, including plasma exchange and immuneadsorption.

Cite this article

WAN Li , WANG Mei . Interpretation on the 2023 clinical practice guidelines of plasma component purification technology from the American Society for Apheresis (9th edition) [J]. Chinese Journal of Blood Purification, 2024 , 23(01) : 1 -8 . DOI: 10.3969/j.issn.1671-4091.2024.01.001

References

[1]Connelly-Smith L, Alquist CR, Aqui NA, Hofmann JC, Klingel R, Onwuemene OA, Patriquin CJ, Pham HP, Sanchez AP, Schneiderman J, Witt V, Zantek ND, Dunbar NM.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue. [J]. J Clin Apher, 2023, 38(2):77-278
Outlines

/

[an error occurred while processing this directive]